TREATMENT WITH ANTI-KIR3DL2 AGENTS
- 专利权人:
- INNATE PHARMA
- 发明人:
- CARINE PATUREL,HELENE SICARD
- 申请号：
- US16343796
- 公开号：
- US20190248895A1
- 申请日:
- 2017.10.19
- 申请国别(地区):
- US
- 年份:
- 2019
- 代理人:
- 摘要：
- This disclosure relates to the use of KIR3DL2-targeting agents for the treatment of CTCL. The invention provides advantageous treatment regimens using anti-KIR3DL2 antibodies for the treatment of CTCL, notably in first-line CTCL.
- 来源网站：
- 中国工程科技知识中心
